Unlocking the Endocannabinoid System in Dermatology: Advancing Cannabinoid-Based Therapeutics Across Inflammation, Barrier Dysfunction & Wound Repair
- Examining the biological role of CB1, CB2 and endocannabinoid signaling pathways in skin homeostasis, inflammation and tissue repair, identifying opportunities for therapeutic intervention across dermatological disorders
- Reviewing emerging preclinical and translational evidence supporting cannabinoid-targeted approaches in inflammatory skin disease, wound healing and barrier restoration, to evaluate where meaningful clinical signals may be achieved
- Leveraging dermatology as an efficient proof-of-concept setting for cannabinoid drug development, using accessible tissues and topical delivery strategies to accelerate human translation and de-risk broader development programs